Company: AEMD
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001683168-25-006049
Chunk: 14

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 1
Chunk 14
---
    $178,206 
  
    Accrued professional fees 
     205,490  
     247,631 
  
    Accrued resale registration 
     46,327  
     46,327 
  
    Total other current liabilities 
    $364,544  
    $472,164 

8. STOCK COMPENSATION

All of the stock-based compensation expense recorded
during the three months ended June 30, 2025 and 2024, an aggregate of $72,442 and $139,328, respectively, is included in payroll and related
expense in the accompanying condensed consolidated statements of operations. Stock-based compensation expense recorded during each of
the three months ended June 30, 2025 and 2024 represented an impact on basic and diluted loss per common share of $(0.03) and $(0.15),
respectively.

Stock Option Activity

We did not issue any stock options during the three
months ended June 30, 2025 and 2024.

Stock options outstanding that have vested as of June
30, 2025 and stock options that are expected to vest subsequent to June 30, 2025 are as follows:

    Schedule of stock options outstanding 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Contractual Term in Years 
  
    Vested 
     6,000  
    $132.13  
     5.80 
  
    Expected to vest 
     546  
    $112.80  
     6.62 
  
    Total 
     6,546  

A summary of stock option activity during the three
months ended June 30, 2025 is presented below:

    Schedule of stock option activity

    Amount

    Range of
Exercise Price

    Weighted
Average 
Exercise
Price

    Outstanding at beginning of year

    6,546

    $
    112.80 – 201.60

    $
    130.52

    Granted

    –

    $
    –

    $
    –

    Cancelled/Expired

    –

    $
    –

    $
    –

    Outstanding June 30, 2025

    6,546

    $
    112.80 – 201.60

    $
    130.52

    Exercisable, June 30, 2025

    6,000